DrugPatentWatch Database Preview
BROMOCRIPTINE MESYLATE Drug Profile
» See Plans and Pricing
Which patents cover Bromocriptine Mesylate, and when can generic versions of Bromocriptine Mesylate launch?
Bromocriptine Mesylate is a drug marketed by Lek Pharm, Mylan, Zydus Pharms Usa Inc, Paddock Llc, and Sandoz Inc. and is included in six NDAs.
The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bromocriptine Mesylate
A generic version of BROMOCRIPTINE MESYLATE was approved as bromocriptine mesylate by SANDOZ INC on January 13th, 1998.
Summary for BROMOCRIPTINE MESYLATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 71 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,157 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for BROMOCRIPTINE MESYLATE |
| What excipients (inactive ingredients) are in BROMOCRIPTINE MESYLATE? | BROMOCRIPTINE MESYLATE excipients list |
| DailyMed Link: | BROMOCRIPTINE MESYLATE at DailyMed |
Recent Clinical Trials for BROMOCRIPTINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| VeroScience | Phase 1 |
| Mylan Pharmaceuticals | Phase 1 |
| VeroScience | Phase 3 |
Pharmacology for BROMOCRIPTINE MESYLATE
| Drug Class | Ergot Derivative |
Medical Subject Heading (MeSH) Categories for BROMOCRIPTINE MESYLATE
US Patents and Regulatory Information for BROMOCRIPTINE MESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lek Pharm | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | CAPSULE;ORAL | 075100-001 | Dec 10, 1998 | DISCN | No | No | Get Started Free | Get Started Free | Get Started Free | ||||
| Mylan | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | TABLET;ORAL | 076962-001 | Sep 24, 2004 | DISCN | No | No | Get Started Free | Get Started Free | Get Started Free | ||||
| Mylan | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | CAPSULE;ORAL | 077226-001 | Apr 4, 2005 | AB | RX | No | Yes | Get Started Free | Get Started Free | Get Started Free | |||
| Zydus Pharms Usa Inc | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | CAPSULE;ORAL | 078899-001 | Jul 30, 2008 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
